Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Edible Sulfonated Soy Protein Microcarriers for Cultivated Meat Cell Expansion.

Journal of biomedical materials research. Part A·2026
Same author

GelMA Hydrogel Stiffness Modulates IL-6- and BMP-2-Induced Immune Dysregulation in Human Mesenchymal Stem Cells.

Biomedicines·2026
Same author

Mechanically graded granular scaffolds for osteochondral tissue engineering.

Biomaterials advances·2026
Same author

Dynamic Compression of Spheroid-Laden Alginate Granular Composites Induces Hypertrophic Chondrocyte Phenotype.

bioRxiv : the preprint server for biology·2026
Same author

Modulating iMSC Spheroid Function with Mechanically Tunable Hydrogels to Strengthen the Bone-Muscle Axis.

ACS biomaterials science & engineering·2025
Same author

Myogenesis and Inflammatory Response of Fibro-Adipogenic Progenitors are Regulated by Hydrogel Biophysical Properties.

ACS applied bio materials·2025

Related Experiment Video

Updated: Jun 11, 2025

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

3.3K

Tissue-Engineered Three-Dimensional Platforms for Disease Modeling and Therapeutic Development.

Erika E Wheeler1,2, J Kent Leach1,2

  • 1Department of Orthopaedic Surgery, UC Davis Health, Sacramento, California, USA.

Tissue Engineering. Part B, Reviews
|September 30, 2024
PubMed
Summary

Three-dimensional (3D) tissue-engineered models offer advanced in vitro disease modeling, overcoming limitations of traditional methods. This review covers technologies, applications, and future directions for these complex biological systems.

Keywords:
disease modelingmicrophysiological systemsorganoidsspheroidstherapeutics

More Related Videos

Tissue Engineering of a Human 3D in vitro Tumor Test System
11:12

Tissue Engineering of a Human 3D in vitro Tumor Test System

Published on: August 6, 2013

21.3K
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
10:03

Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells

Published on: July 5, 2019

8.7K

Related Experiment Videos

Last Updated: Jun 11, 2025

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

3.3K
Tissue Engineering of a Human 3D in vitro Tumor Test System
11:12

Tissue Engineering of a Human 3D in vitro Tumor Test System

Published on: August 6, 2013

21.3K
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
10:03

Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells

Published on: July 5, 2019

8.7K

Area of Science:

  • Biotechnology and Biomedical Engineering
  • Regenerative Medicine
  • In Vitro Disease Modeling

Background:

  • Traditional 2D cell cultures and animal models have limitations in recapitulating human tissue complexity and disease pathology.
  • Three-dimensional (3D) tissue engineering presents a promising alternative for creating more physiologically relevant in vitro models.
  • Advances in biomaterials, cell sourcing, and fabrication technologies are driving the development of sophisticated 3D tissue models.

Purpose of the Study:

  • To review recent advancements in 3D tissue-engineered models for in vitro disease modeling.
  • To discuss the technologies, advantages, and limitations of current 3D platforms across various organ systems.
  • To highlight future directions for enhancing the reliability and application of 3D tissue models in research and drug development.

Main Methods:

  • Literature review of recent research and technological developments in 3D tissue engineering.
  • Analysis of 3D model applications in modeling diseases of the cardiovascular, gastrointestinal, bone marrow, neural, reproductive, and pulmonary systems.
  • Discussion of key considerations, challenges, and future prospects for 3D tissue and disease modeling.

Main Results:

  • 3D tissue-engineered models demonstrate significant potential to recapitulate complex tissue architecture and function.
  • These models are being developed for a wide range of organs, offering improved in vitro disease modeling capabilities.
  • Current technologies present advantages and limitations that need careful consideration for specific applications.

Conclusions:

  • 3D tissue-engineered models are advancing the field of in vitro disease modeling, providing more accurate preclinical platforms.
  • Further technological advancements are crucial to enhance the predictive power and reliability of these models for tissue development and disease research.
  • Optimized 3D models hold promise for accelerating drug discovery and understanding complex pathologies.